Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Alocane** is a Quest Products over-the-counter topical burn-care brand used for temporary relief of pain and itching associated with minor burns, including sunburn. The core burn-relief products use lidocaine hydrochloride 4% as a topical local anesthetic; certain Alocane Plus and Alocane Max products additionally contain benzalkonium chloride 0.13% as a first-aid antiseptic. Lidocaine inhibits sodium-ion fluxes required for nerve-impulse initiation and conduction, producing local anesthesia and reducing burn-associated pain. Alocane drug products are marketed as topical gels, sprays, and medicated burn pads. ([alocane.com](https://alocane.com/a/docs/burn-treatment/burn-pain-relief))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Alocane.